AU2002314705A1 - Adenovirus serotype 30 (ad30) fiber protein and uses thereof - Google Patents
Adenovirus serotype 30 (ad30) fiber protein and uses thereofInfo
- Publication number
- AU2002314705A1 AU2002314705A1 AU2002314705A AU2002314705A AU2002314705A1 AU 2002314705 A1 AU2002314705 A1 AU 2002314705A1 AU 2002314705 A AU2002314705 A AU 2002314705A AU 2002314705 A AU2002314705 A AU 2002314705A AU 2002314705 A1 AU2002314705 A1 AU 2002314705A1
- Authority
- AU
- Australia
- Prior art keywords
- fiber protein
- adenovirus serotype
- serotype
- adenovirus
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/758,008 | 2001-01-09 | ||
US09/758,008 US6635466B2 (en) | 2001-01-09 | 2001-01-09 | Adenovirus serotype 30 (Ad30) |
US33928201P | 2001-12-11 | 2001-12-11 | |
US60/339,282 | 2001-12-11 | ||
PCT/US2002/000362 WO2002083902A2 (en) | 2001-01-09 | 2002-01-09 | Adenovirus serotype 30 (ad30) fiber protein and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002314705A1 true AU2002314705A1 (en) | 2002-10-28 |
Family
ID=26991550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002314705A Abandoned AU2002314705A1 (en) | 2001-01-09 | 2002-01-09 | Adenovirus serotype 30 (ad30) fiber protein and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002314705A1 (en) |
WO (1) | WO2002083902A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004111251A2 (en) * | 2003-06-11 | 2004-12-23 | The Scripps Research Institute | Modified fiber proteins for efficient receptor binding |
FR2860004A1 (en) * | 2003-09-18 | 2005-03-25 | Roussy Inst Gustave | Adenoviral vector encoding modified capsid protein, useful in gene therapy of e.g. cancer and cystic fibrosis, can infect cells deficient in, or lacking, the common receptor for Coxsackie virus B3 and adenovirus |
CN107058359B (en) * | 2017-04-14 | 2019-08-13 | 北京交通大学 | A kind of high-throughput screening method of anti respiratory syncytial virus drug and application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5877011A (en) * | 1996-11-20 | 1999-03-02 | Genzyme Corporation | Chimeric adenoviral vectors |
US20030017138A1 (en) * | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
-
2002
- 2002-01-09 AU AU2002314705A patent/AU2002314705A1/en not_active Abandoned
- 2002-01-09 WO PCT/US2002/000362 patent/WO2002083902A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002083902A3 (en) | 2003-08-14 |
WO2002083902A2 (en) | 2002-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1340000A (en) | Novel adenoviral vector and methods for making and using the same | |
AU2002360733A1 (en) | SUBSTITUTED 4,9-DIHYDROCYCLOPENTA(imn)PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES | |
AU2001227833A1 (en) | 71 human secreted proteins | |
AU2001245308A1 (en) | 207 human secreted proteins | |
AU2001237957A1 (en) | 17 human secreted proteins | |
AU2002314705A1 (en) | Adenovirus serotype 30 (ad30) fiber protein and uses thereof | |
AU2001273099A1 (en) | Substituted 4,9-dihydrocyclopenta(imn) phenanthridine-5-ones, derivatives thereof and their uses | |
AU2002312373A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002332736A1 (en) | New adenovirus type 7 vectors | |
AU2001255668A1 (en) | 29 human secreted proteins | |
AU2001285109A1 (en) | Microtubule-associated proteins and tubulins | |
AU2001229503A1 (en) | 17 human secreted proteins | |
AU2001263287A1 (en) | Human protein kinase "13305" and uses therefor | |
AU2002365153A1 (en) | 41 human secreted proteins | |
AU2001229563A1 (en) | 21 human secreted proteins | |
AU2002344829A1 (en) | Human ugrp (uteroglobin-related protein) 1 promoter and its use | |
AU2002327176A1 (en) | 20 human secreted proteins | |
AU2002360333A1 (en) | Human angiomotin-like protein 1 | |
AU3375500A (en) | Adenoviral vectors, proteins and methods for their use | |
AU2659801A (en) | Shc associated protein 140 (sap-140) | |
AU2001230942A1 (en) | 7 human secreted proteins | |
AU2002343516A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002320621A1 (en) | Structural and cytoskeleton-associated proteins | |
AU2002246998A1 (en) | 50 human secreted proteins | |
AU2002221595A1 (en) | Expression cassettes and adenovirus vectors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |